Research map: Tertiary lymphoid structure transcriptomic signatures show limited and cohort-dependent value for predicting axillary nodal involvement in oestrogen receptor-positive luminal breast cancer

Back to the article

Papers in this map

  1. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods · Professor Gary S. Collins · 2024 · 3668 citations · Cited by this paper
  2. Temozolomide-based therapy may remodel the tumor microenvironment and enhance immunotherapy sensitivity in advanced leiomyosarcoma · 2026 · Related
  3. Tertiary lymphoid structures improve immunotherapy and survival in melanoma · Rita Cabrita · 2020 · 2483 citations · Cited by this paper
  4. Activation of the caspase-1/gasdermin D pathway via α-linolenic acid-mediated GPR120 signaling induces pyroptosis and suppresses ovarian cancer tumor growth · 2025 · Related
  5. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer · Fátima Cardoso · 2016 · 2100 citations · Cited by this paper
  6. Growth differentiation factor-11 inhibits the progression of acute myeloid leukemia and increases chemosensitivity by inhibiting cathepsin S · 2026 · Related
  7. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis · Armando E. Giuliano · 2017 · 1942 citations · Cited by this paper
  8. Treatment of HRD-positive elderly ovarian cancer patient: a case report · 2025 · Related
  9. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial · Mila Donker · 2014 · 1893 citations · Cited by this paper
  10. Prochlorperazine inhibits the proliferation of hepatocellular carcinoma cells by promoting phosphorylation of β-catenin · 2026 · Related
  11. The Hazards of Hazard Ratios · Miguel Ángel Hernán · 2009 · 1396 citations · Cited by this paper
  12. Successful treatment with erlotinib plus ramucirumab in a patient with non-small-cell lung cancer harboring EGFR exon 20 insertion mutation · 2025 · Related
  13. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement · Professor Gary S. Collins · 2015 · 923 citations · Cited by this paper
  14. Dual checkpoint inhibition achieves successful treatment of diffuse bilateral lung metastasis in giant advanced liver cancer: a case report · 2026 · Related
  15. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer · Maxime Meylan · 2022 · 853 citations · Cited by this paper
  16. Akt inhibitor-IV in estrogen receptor-positive breast cancer cells: cytotoxic, apoptotic, transcriptional, and in-silico comparison with tamoxifen · 2026 · Related
  17. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes · Oreste ­Gentilini · 2023 · 567 citations · Cited by this paper
  18. SENP3-mediated deSUMOylation stabilizes programmed death-ligand 1 to promote immune evasion in hepatocellular carcinoma · 2026 · Related
  19. Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array Profiling · Domenico Coppola · 2011 · 434 citations · Cited by this paper
  20. Histone lactylation promoted colorectal cancer progression by enhancing tumor necrosis factor transcription and served as a diagnostic biomarker · 2025 · Related
  21. Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial · Sanne A. L. Bartels · 2022 · 389 citations · Cited by this paper
  22. Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial · Toralf Reimer · 2024 · 307 citations · Cited by this paper
  23. Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases · Jana de Boniface · 2024 · 303 citations · Cited by this paper
  24. A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer · Sandra Tietscher · 2023 · 227 citations · Cited by this paper
  25. Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes · Sangeetha Prabhakaran · 2017 · 154 citations · Cited by this paper
  26. Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes · Pin‐Ji Lei · 2023 · 68 citations · Cited by this paper
  27. Prognostic impact of tertiary lymphoid structures in breast cancer prognosis: a systematic review and meta-analysis · Nana Zhang · 2021 · 67 citations · Cited by this paper
  28. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study · Giacomo Montagna · 2024 · 51 citations · Cited by this paper
  29. Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial · Jana de Boniface · 2024 · 37 citations · Cited by this paper
  30. Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer · Qing Wang · 2024 · 32 citations · Cited by this paper
  31. Paracrine Orchestration of Tumor Microenvironment Remodeling Induced by GLO1 Potentiates Lymph Node Metastasis in Breast Cancer · Jindong Xie · 2025 · 27 citations · Cited by this paper
  32. The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative Review · Dana P. Narvaez · 2024 · 24 citations · Cited by this paper
  33. Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features · Florence Boissière‐Michot · 2024 · 24 citations · Cited by this paper
  34. Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study · Giacomo Montagna · 2025 · 22 citations · Cited by this paper
  35. Prediction of High Nodal Burden in Patients With Sentinel Node–Positive Luminal ERBB2 -Negative Breast Cancer · Ida Dalene Skarping · 2024 · 15 citations · Cited by this paper
  36. Association between tertiary lymphoid structures and clinical outcomes in cancer patients treated with immune checkpoint inhibitors: an updated meta-analysis · Lingli Li · 2024 · 13 citations · Cited by this paper
  37. Genomic Characteristics Related to Histology-Based Immune Features in Breast Cancer · Yoon Jin Cha · 2025 · 9 citations · Cited by this paper
  38. Mature Tertiary Lymphoid Structures in Breast Cancers Are Associated With Antitumor Immunity and Better Prognosis · Shibo Yu · 2026 · 4 citations · Cited by this paper
  39. Axillary clearance and chemotherapy rates in ER+HER2− breast cancer: secondary analysis of the SENOMAC trial · Tove Filtenborg Tvedskov · 2024 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)